Protalix BioTherapeutics Inc (PLX)
1.055
-0.20
(-15.60%)
USD |
NYAM |
May 10, 12:02
Protalix BioTherapeutics Price: 1.055 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 09, 2024 | 1.13 | 1.25 | 1.12 | 1.25 | 792300.0 |
May 08, 2024 | 1.15 | 1.16 | 1.115 | 1.14 | 286011.0 |
May 07, 2024 | 1.13 | 1.16 | 1.12 | 1.14 | 225755.0 |
May 06, 2024 | 1.13 | 1.16 | 1.07 | 1.11 | 1.009M |
May 03, 2024 | 1.17 | 1.185 | 1.13 | 1.14 | 231575.0 |
May 02, 2024 | 1.16 | 1.195 | 1.16 | 1.16 | 218874.0 |
May 01, 2024 | 1.17 | 1.22 | 1.12 | 1.21 | 355268.0 |
Apr 30, 2024 | 1.20 | 1.21 | 1.12 | 1.14 | 384188.0 |
Apr 29, 2024 | 1.14 | 1.24 | 1.13 | 1.20 | 667963.0 |
Apr 26, 2024 | 1.19 | 1.22 | 1.09 | 1.15 | 958735.0 |
Apr 25, 2024 | 1.21 | 1.22 | 1.16 | 1.18 | 192155.0 |
Apr 24, 2024 | 1.19 | 1.225 | 1.17 | 1.21 | 228353.0 |
Apr 23, 2024 | 1.16 | 1.24 | 1.16 | 1.20 | 272095.0 |
Apr 22, 2024 | 1.15 | 1.18 | 1.12 | 1.18 | 225065.0 |
Apr 19, 2024 | 1.12 | 1.166 | 1.10 | 1.15 | 449804.0 |
Apr 18, 2024 | 1.16 | 1.17 | 1.09 | 1.13 | 427188.0 |
Apr 17, 2024 | 1.15 | 1.20 | 1.135 | 1.15 | 366338.0 |
Apr 16, 2024 | 1.14 | 1.17 | 1.13 | 1.14 | 291488.0 |
Apr 15, 2024 | 1.20 | 1.21 | 1.14 | 1.14 | 429154.0 |
Apr 12, 2024 | 1.23 | 1.24 | 1.18 | 1.18 | 342149.0 |
Apr 11, 2024 | 1.28 | 1.28 | 1.20 | 1.22 | 287765.0 |
Apr 10, 2024 | 1.31 | 1.33 | 1.25 | 1.26 | 316235.0 |
Apr 09, 2024 | 1.30 | 1.35 | 1.29 | 1.32 | 220438.0 |
Apr 08, 2024 | 1.17 | 1.33 | 1.17 | 1.30 | 905577.0 |
Apr 05, 2024 | 1.22 | 1.23 | 1.17 | 1.17 | 426732.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.81
Minimum
Jan 27 2022
6.45
Maximum
Feb 09 2021
2.305
Average
1.915
Median
Price Benchmarks
Agenus Inc | 10.68 |
InfuSystems Holdings Inc | 7.51 |
AIM ImmunoTech Inc | 0.435 |
Perspective Therapeutics Inc | 1.705 |
Armata Pharmaceuticals Inc | 3.01 |
Price Related Metrics
PE Ratio | 52.75 |
PS Ratio | 1.253 |
Price to Book Value | 2.296 |
Earnings Yield | 1.90% |
Market Cap | 77.07M |
Operating PE Ratio | 7.843 |
Normalized PE Ratio | 52.75 |